Autopsy report · NCT01223001

Feasibility Study of Duloxetine in the Treatment of Depression in Patients With Traumatic Brain Injury

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“Most potential subjects had already been prescribed Cymbalta.”

The sponsor’s own words in the registry.

Life of this trial

Registered 14 years 1 month after it had already started.
Ran for about 14 years 10 months before it stopped.
8 participants enrolled.
Results were posted on the registry 3 years 5 months after it ended.

Vital statistics

Status: Terminated
Phase: Phase 2
Sponsor: Rehabilitation Hospital of Indiana
Sponsor type: University, hospital or other
Conditions: Traumatic Brain Injury; Depression
Interventions: Duloxetine; Sugar pill
Participants: 8
Sites: 1
Countries: United States

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.